WIF1 and Hepatic fibrosis: For this purpose, we investigated the potential efficacy and mechanisms of dasatinib in the treatment of thioacetamide-induced liver fibrosis in mice through the modulation of miR-378 and miR-17 that can target Wnt-10 and WIF1, respectively, and inhibit the Wnt/β-catenin pathway.